Bifidobacterium and enteral feeding in preterm infants: Cluster-randomized trial

Pediatrics International

Volumn 56, Issue 5, 2014, Pages 714-719

  Totsu, Satsuki ^a   Yamasaki, Chika ^b   Terahara, Masaki ^c   Uchiyama, Atsushi ^a   Kusuda, Satoshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Aiiku Hospital   (Japan)

^c MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

establishment of enteral feeding; necrotizing enterocolitis; neonate; probiotics; sepsis

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM BIFIDUM; CHILD GROWTH; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; HUMAN; INCIDENCE; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; VERY LOW BIRTH WEIGHT; WEIGHT GAIN; BIFIDOBACTERIUM; CLINICAL TRIAL; NEWBORN;

BIFIDOBACTERIUM; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE;

EID: 84939266284     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12330     Document Type: Article

References (24)

1. Cilieborg MS, Boye M, Sangild PT,. Bacterial colonization and gut development in preterm neonates. Early Hum. Dev. 2012; 88: S41-49.
2. Westerbeek EA, van den Berg A, Lafeber HN, et al. The intestinal bacterial colonisation in preterm infants: A review of the literature. Clin. Nutr. 2006; 25: 361-368.
3. Sherman MP,. New concepts of microbial translocation in the neonatal intestine: Mechanisms and prevention. Clin. Perinatol. 2010; 37: 565-579.
4. Alfaleh K, Anabrees J, Bassler D, et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2011; (3): CD005496.
5. Yamasaki C, Totsu S, Uchiyama A, et al. Effect of Bifidobacterium administration on very-low-birthweight infants. Pediatr. Int. 2012; 54: 651-656.
6. Kusuda S, Fujimura M, Sakuma I, et al. Morbidity and mortality of infants with very low birth weight in Japan: Center variation. Pediatrics 2006; 118: e1130-1138.
7. Leaf A, Dorling J, Kempley S, et al. Early or delayed enteral feeding for preterm growth-restricted infants: A randomized trial. Pediatrics 2012; 129: e1260-1268.
8. Al-Hosni M, Duenas M, Hawk M, et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J. Perinatol. 2012; 32: 253-259.
9. Kitajima H, Sumida Y, Tanaka R, et al. Early administration of Bifidobacterium breve to preterm infants: Randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 1997; 76: F101-107.
10. Lee SJ, Cho SJ, Park EA,. Effects of probiotics on enteric flora and feeding tolerance in preterm infants. Neonatology 2007; 91: 174-179.
11. Chou IC, Kuo HT, Chang JS, et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J. Pediatr. 2010; 156: 393-396.
12. Underwood MA, Salzman NH, Bennett SH, et al. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: Impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J. Pediatr. Gastroenterol. Nutr. 2009; 48: 216-225.
13. Khailova L, Dvorak K, Arganbright KM, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 297: G940-949.
14. Khailova L, Mount Patrick SK, Arganbright KM, et al. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2010; 299: G1118-1127.
15. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121: 580-591.
16. Stratiki Z, Costalos C, Sevastiadou S, et al. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum. Dev. 2007; 83: 575-579.
17. Kusuda S, Fujimura M, Uchiyama A, et al. Trends in morbidity and mortality among very low birth weight infants from 2003 to 2008 in Japan. Pediatr. Res. 2012; 72: 531-538.
18. Nakamura Y, Terahara M, Yajima M, et al. Effect of Bifidobacterium bifidum OLB6377 and Bifidobacterium bifidum OLB6378 on expression of the human polymeric immunoglobulin receptor (pIgR). Digest. Org. Mucos. Immunol. 2005; 42: 53-56 (in Japanese with English abstract).
19. Nakamura Y, Terahara M, Iwamoto T, et al. Up-regulation of polymeric immunoglobulin receptor expression by the heat-inactivated potential probiotic Bifidobacterium bifidum OLB6378 in a mouse intestinal explant model. Scand. J. Immunol. 2011; 75: 176-183.
20. Hayes JA, Adamson-Macedo EN, Perera S, et al. Detection of secretory immunoglobulin A (SIgA) in saliva of ventilated and non-ventilated preterm neonates. Neuroendocrinol. Lett. 1999; 20: 109-113.
21. Wan AK, Seow WK, Purdie DM, et al. Immunoglobulins in saliva of preterm and full-term infants. Oral Microbiol. Immunol. 2003; 18: 72-78.
22. Fujii T, Ohtsuka Y, Lee T, et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J. Pediatr. Gastroenterol. Nutr. 2006; 43: 83-88.
23. Campeotto F, Suau A, Kapel N, et al. A fermented formula in pre-term infants: Clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br. J. Nutr. 2011; 22: 1-10.
24. Mohan R, Koebnick C, Schildt J, et al. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr. Res. 2008; 64: 418-422.